Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Commit To Buy Capricor Therapeutics At $3, Earn 69.5% Annualized Using Options

Investors considering a purchase of Capricor Therapeutics Inc (Symbol: CAPR) shares, but cautious about paying the going market price of $6.33/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

Friday assorted links

1. Dwarkesh interviews Robert Caro (!). 2. New and pretty brutal results on CTE and football. 3. Interview with Dan Wang. 4. Updated version of the Saez-Zucman audit.

More from Friday 30 October →